Dystrophine Myotubes Biomarker Errance diagnostique Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS C2C12 AAV VECTOR Myologie Dilated cardiomyopathy Skeletal muscle Base de données FAIR Adult SMA Butyrylcholinesterase Biological sciences Congenital muscular dystrophy Exome A-type lamin Allele-specific silencing therapy Lamin A/C nuclei Cardiac conduction system C elegans Maladies rares LMNA gene Titin Acetyltransferase Calcium handling Hypermobile EDS Clinical trial Myogenesis Actionability Mouse Laminopathy Muscular dystrophy MD Alternative splicing Treatment delay Laminopathie RNA interference Therapy BiP A-type lamins Muscle Centronuclear myopathy Laminopathies Lamin A/C Actionable gene Muscular dystrophy Cardiology Next generation sequencing Emery-Dreifuss muscular dystrophy POPDC1 Muscle biopsy Muscle MRI INPP5K Treatment Diagnosis Cancer COVID-19 Patient registry Emerin Regeneration Neuromuscular diseases Angiotensin-converting enzyme inhibitor Nuclear envelope CRISPR Connective tissue LGMD CMTX Angiotensin-converting enzyme inhibitors Rare diseases Dynamin 2 Dystrophie musculaire Myopathy GNE COL6A1 Lamin A/C LMNA gene Maladies rares et orphelines COL6A3 Collagen VI-related myopathies NGS collagen type VI congenital muscular dystrophy CMD limb-girdle muscular dystrophy LGMD muscular MRI neuromuscular disorders Cancer biomarkers Cardiomyopathy COL1A1 Mutations Heart failure Becker muscular dystrophy Autophagosome maturation CSF protein Rare neuromuscular diseases Duchenne muscular dystrophy LMNA-related congenital muscular dystrophy Allele-specific silencing Ehlers‐Danlos Syndrome Myopathies Allele‐specific silencing therapy Heart AAV BVES Lamins LMNA Gene therapy Joint laxity IPSC